VALBIOTIS
Regulatory News:
Valbiotis (FR0013254851 – ALVAL, PEA/SME eligible) (Paris:ALVAL), a Research and Development company committed to scientific innovation for preventing and combating metabolic diseases, announces the release of the latest issue of its Letter to Shareholders, for 2021.
In this Letter to Shareholders:
- A message from Sébastien PELTIER, CEO, Chairman of the Valbiotis Management Board;
- A summary of the Company’s latest news;
- An update on the progress of the active substances development plan.
The Letter to shareholders can be consulted in the "Investors" area of the Valbiotis website, in the "Shareholder area " section.
To receive the next editions, shareholders are invited to register here .
About Valbiotis
Valbiotis is a Research & Development company committed to scientific innovation for the treatment and prevention of metabolic diseases in response to unmet medical needs.
Valbiotis has adopted an innovative approach, aiming to revolutionize healthcare by developing a new class of health nutrition products designed to reduce the risk of major metabolic diseases, based on a multi-target approach enabled by the use of plant-based ingredients.
Its products are intended to be licensed to players in the health sector.
Created at the beginning of 2014 in La Rochelle, the Company has forged numerous partnerships with leading academic centers. The Company has established three sites in France – Périgny, La Rochelle (17) and Riom (63) – and a subsidiary in Quebec City (Canada).
Valbiotis is a member of the "BPI Excellence" network and has been recognized as an "Innovative Company" by the BPI label. Valbiotis has also been awarded "Young Innovative Company" status and has received major financial support from the European Union for its research programs via the European Regional Development Fund (ERDF). Valbiotis is a PEA-SME eligible company.
For more information about Valbiotis, please visit: www.valbiotis.com
Name: Valbiotis
ISIN code: FR0013254851
Mnemonic code: ALVAL
EnterNext© PEA-PME 150
This press release contains forward-looking statements about Valbiotis’ objectives. Valbiotis considers that these projections are based on rational hypotheses and the information available to Valbiotis at the present time. However, in no way does this constitute a guarantee of future performance, and these projections may be affected by changes in economic conditions and financial markets, as well as certain risks and uncertainties, including those described in the Valbiotis Universal Registration Document approved by the French Financial Markets Regulator (AMF) on July 27, 2021 (application number R 21-039). This document is available on the Company’s website (www.valbiotis.com
).
This press release and the information it contains do not constitute an offer to sell or subscribe, or a solicitation to purchase or subscribe to Valbiotis’ shares or financial securities in any country.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210909005474/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phenom Named Strategic Leader in 2025 Fosway 9-Grid™ for Talent & People Success for Second Consecutive Year29.10.2025 14:30:00 CET | Press release
Positioning Recognises Phenom Applied AI Phenom, an applied AI company that helps organizations hire faster, develop better and retain longer, has been named a Strategic Leader in the 2025 Fosway 9-Grid™ for Talent and People Success for the second consecutive year, changing their position by demonstrating increased performance for enterprises while lowering the total cost of ownership. The placement is a testament to the value delivered by its AI, automation and experience approach. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029195746/en/ Phenom has been named a Strategic Leader in the 2025 Fosway 9-Grid™ for Talent and People Success for the second consecutive year, changing their position by demonstrating increased performance for enterprises while lowering the total cost of ownership. The placement is a testament to the value delivered by its AI, automation and experience approach. Fosway Group identifies Strategi
Ferring Pharmaceuticals to Explore Strategic Options for Rebyota®29.10.2025 14:00:00 CET | Press release
As part of our ongoing transformation to sharpen our focus, we have decided to explore strategic options for Rebyota® (faecal microbiota, live – jslm). To date, more than five thousand patients suffering from recurrent Clostridioides difficile infection (rCDI) have found new hope when treated with Rebyota®. Without commercial critical mass in this therapy area at Ferring, we believe that this first-in-class, innovative product could benefit many more patients with a new approach to its continued commercialisation. As a result, Ferring will reduce commercial efforts in the United States while ensuring uninterrupted access for patients. Approved by the U.S. Food and Drug Administration (FDA) in 2022, Rebyota® was the first FDA-approved faecal microbiota transplant, indicated for the prevention of rCDI in adults following antibiotic treatment for recurrent CDI. This milestone marked a significant advancement in understanding the role of the human microbiome in health and disease. Ferring
GigaDevice GD32F5xx and GD32G5xx Software Test Libraries (STL) Receive TÜV Rheinland IEC 61508 Functional Safety Certification29.10.2025 14:00:00 CET | Press release
GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and analog products, announced that its GD32F5xx and GD32G5xx Software Test Libraries have received IEC 61508 SC3 (SIL 2/SIL 3) functional safety certification from TÜV Rheinland. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029124621/en/ Certificate This milestone expands GigaDevice’s functional safety portfolio, which already includes the GD32H7 and GD32F30x STLs, and now covers a broad range of MCUs with Arm® Cortex®-M7, Cortex®-M4, and Cortex®-M33 cores. Building on this foundation, GigaDevice will continue to deliver high-performance and safety-focused hardware and software solutions for key applications such as industrial control, energy and power, and humanoid robotics. With the growing emphasis on safety across industries like industrial automation, functional safety has become a critical considerat
375ai Launches Data Layer for the Physical World on Solana29.10.2025 14:00:00 CET | Press release
375ai, an edge data intelligence company transforming the physical world into structured, machine-readable insights, today announced the launch of its mainnet on Solana. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251028976994/en/ 375ai Launches Data Layer for the Physical World The physical world is generating more data than ever before, but most of it is invisible. Traffic systems, advertising platforms, and governments still rely on outdated infrastructure and fragmented data sources to understand how people and goods move through cities. Centralized data pipelines are expensive, slow, and often limited to incomplete or delayed insights. Meanwhile, AI systems are hungry for real world context not just synthetic inputs. Without structured, real time data, they can’t power smarter mobility, logistics, and safety solutions. 375ai enables real world data capture, unlocking a new category of physical AI infrastructure. At l
Hercle Raises $60M to Scale Institutional-Grade Infrastructure for Global Money Movement29.10.2025 13:30:00 CET | Press release
Round includes $10 million in equity, led by F-Prime, and a $50M credit facility to support global expansionSince launch, Hercle’s platform has processed over $20B in transactions, settling multi-million cross-border flows in stablecoins, digital assets, and fiat within minutes Hercle, an institutional infrastructure platform bridging stablecoins, digital assets, and cross-border settlement, today announced $60 million in new capital. The round features a $10 million equity investment led by F-Prime, with participation from Fulgur Ventures and Exponential Science, alongside a $50 million credit line to support the expansion of institutional services and global growth initiatives. To date, Hercle’s platform has processed more than $20 billion in transactions, enabling global institutions to move millions of dollars across borders and digital assets in minutes. Hercle was built to bridge a critical infrastructure gap in the evolving stablecoin and digital asset ecosystem. As institutions
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom